Aurobindo Pharma Limited has officially announced the resignation of Dr. Sanjay Chaturvedi, the Chief Executive Officer of its wholly owned subsidiary, Apitoria Pharma Private Limited. Dr. Chaturvedi has decided to step down from his leadership position to pursue a new professional opportunity. His departure is effective as of the close of business hours on May 4, 2026.
Leadership Change at Apitoria Pharma
Aurobindo Pharma has confirmed that Dr. Sanjay Chaturvedi has tendered his resignation as the Chief Executive Officer of its wholly owned subsidiary, Apitoria Pharma Private Limited. The company noted that Dr. Chaturvedi is moving on to explore a different professional opportunity. The resignation and subsequent relief from his duties were formalized on May 4, 2026.
Transition Details
The leadership transition at Apitoria Pharma is effective immediately, with Dr. Chaturvedi officially relieved of his responsibilities as of the close of business hours on May 4, 2026. Aurobindo Pharma continues to maintain its operational focus through its established subsidiary structure following this change in the executive team.
Source: BSE
